Treatment (AI-directed analysis, SBRT) for Lung Cancer
This trial tests AI to help improve dose prescription for lung radiation therapy to help reduce local recurrence.
- Lung Cancer
- Non-Small Cell Lung Cancer
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Are there still vacancies for volunteers to join this trial?
"As reported on clinicaltrials.gov, the recruitment for this study has ended as of March 24th 2023. Initially posted on May 31st 2023, this trial is no longer searching for participants; however, there are 6463 other trials that require patients at present time."
What is the fundamental purpose of this clinical experiment?
"Over a duration of two years, the research team will evaluate this study's primary objective of Overall Survival. Secondary metrics include evaluating Respiratory Function via RTOG Pulmonary Function Test Toxicity Scale, Incidence of Adverse Events through National Cancer Institute-Common Terminology Criteria for Adverse Events v5.0., and assessing physician adherence to prescribed doses as recommended by Deep Profiler +iGray software over one to two weeks during SBRT treatment."